| 000 | 01098 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250512022743.0 | ||
| 264 | 0 | _c19850625 | |
| 008 | 198506s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1985.tb02740.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, D A | |
| 245 | 0 | 0 |
_aThe use of benzodiazepines in depression. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _c1985 |
||
| 300 |
_a31S-35S p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xtherapeutic use |
| 650 | 0 | 4 | _aBenzodiazepines |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDepression _xchemically induced |
| 650 | 0 | 4 |
_aDepressive Disorder _xclassification |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 19 Suppl 1 _gp. 31S-35S |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1985.tb02740.x _zAvailable from publisher's website |
| 999 |
_c2865723 _d2865723 |
||